AMI Research Initiates Coverage on Diagnostic Imaging International Corp. With a Speculative Buy Rating of $0.62
May 16 2013 - 11:30AM
Marketwired
AMI Research, a leading provider of equity research reports and a
subsidiary of Hawk Associates Inc., announced today that it has
initiated equity research coverage on Diagnostic Imaging
International Corp. (OTCQB:DIIG) with a Speculative Buy rating of
$0.62 per share.
AMI president Peter J. D'Agostino said, "We think DIIG is poised
for substantial growth with the completion of its first,
stand-alone MRI diagnostic facility. Operating MRI facilities
offers significant sources of revenue for healthcare providers as
the facilities are generally supported by favorable reimbursement
rates from insurers and government programs. We contend that DIIG's
diagnostic business unit will be the catalyst for the company's
significant revenue expansion. In addition, we cannot ignore DIIG's
teleradiology business, which yields positive cash-flow."
AMI Research provides an institutional-quality, equity research
initiation report detailing DIIG's key statistics, management,
growth catalysts, financial outlook, price target, and valuation.
The complete eight-page report is available to download for free at
the AMI Research website,
http://www.amistockreports.com/DIIG_Initiation.pdf.
About AMI Research
AMI Research provides equity research coverage for promising
companies that do not have traditional Wall Street analyst
coverage. Coverage by AMI ensures an objective explanation of all
facets of a business and increased exposure to numerous
institutional and retail investors seeking reputable investment
ideas. AMI combines in-depth, insightful research and customized
graphics into detailed analyst reports to create an investment
thesis with a four tier rating system and 12-month price target.
These reports detail the company's industry, strategic position,
core business model, financial history, future growth catalysts and
projected financials. Please visit www.amistockreports.com.
About Diagnostic Imaging International Corp.
Diagnostic Imaging International Corp., ("DIIG") owns and
operates CTS a Teleradiology company, and SMI an MRI clinic.
Teleradiology is the process of assessing radiological patient
images, such as x-rays, CTs, and MRIs, from one location to another
for the purposes of interpretation and/or consultation. CTS
provides remote radiology (teleradiology) technology to hospitals
and practices, on-call 24 hours a day, 7days a week. CTS connects
clients with a global teleradiology network, providing access to
global partner facilities and American and Canadian board-certified
radiologists. SMI provides full out-patient MRI diagnostic scans
and results, and offers its patients both an open MRI and closed
1.5T MRI depending on needs and requirements.
To find out more about Diagnostic Imaging International Corp.
(OTCQB:DIIG), visit our website at www.diig.biz.
Contacts: AMI Research Peter J. D'Agostino President
212-541-2465p.dagostino@amistockreports.com www.amistockreports.com
Diagnostic Imaging International Corp. (877) 331-3444
www.diig.biz
Medical Imaging (CE) (USOTC:MEDD)
Historical Stock Chart
From Oct 2024 to Nov 2024
Medical Imaging (CE) (USOTC:MEDD)
Historical Stock Chart
From Nov 2023 to Nov 2024